|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 489.60 CHF | -1.39% |
|
-6.85% | -8.96% |
| 03-09 | Lonza Extends Long-term Production Tie-up for Genetix's Gene Therapy | MT |
| 03-09 | Lonza Group and Genetix Biotherapeutics extend commercial manufacturing agreement for Zynteglo | RE |
| Capitalization | 34.87B 44.7B 38.62B 33.35B 60.78B 4,122B 62.49B 412B 164B 1,971B 168B 164B 7,099B | P/E ratio 2025 |
39.8x | P/E ratio 2026 * | 30.2x |
|---|---|---|---|---|---|
| Enterprise value | 38.33B 49.14B 42.46B 36.66B 66.82B 4,531B 68.7B 453B 181B 2,167B 184B 180B 7,804B | EV / Sales 2025 |
6.28x | EV / Sales 2026 * | 5.34x |
| Free-Float |
93.86% | Yield 2025 |
0.93% | Yield 2026 * | 1.09% |
Last Transcript: Lonza Group AG
| 1 day | -2.27% | ||
| 1 week | -6.85% | ||
| Current month | -8.69% | ||
| 1 month | -3.39% | ||
| 3 months | -6.60% | ||
| 6 months | -12.32% | ||
| Current year | -8.96% |
| 1 week | 485.8 | 526.4 | |
| 1 month | 485.8 | 542.4 | |
| Current year | 485.8 | 585.6 | |
| 1 year | 467.8 | 605.2 | |
| 3 years | 308.6 | 616 | |
| 5 years | 308.6 | 785.4 | |
| 10 years | 152.8 | 785.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wolfgang Wienand
CEO | Chief Executive Officer | 54 | 01/07/2024 |
Philippe Deecke
DFI | Director of Finance/CFO | 54 | 01/12/2021 |
Daniel Buchta
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 65 | 16/04/2014 |
| Director/Board Member | 68 | 16/04/2014 | |
Christoph Mäder
BRD | Director/Board Member | 66 | 26/04/2016 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.39% | -6.85% | -8.31% | -6.92% | 44.92B | ||
| -2.21% | +0.32% | +22.09% | +34.99% | 33.88B | ||
| +1.46% | -7.11% | +18.65% | +47.53% | 30.76B | ||
| +0.38% | -3.26% | -6.21% | -13.14% | 28.69B | ||
| +0.95% | -1.63% | +155.95% | +340.83% | 19.59B | ||
| -5.53% | -5.03% | +57.41% | +112.95% | 14.76B | ||
| +2.17% | +2.20% | +46.11% | +173.15% | 13.25B | ||
| -0.75% | -5.48% | +25.26% | +0.16% | 13.06B | ||
| -2.63% | -6.60% | +22,303.39% | +3,308.37% | 12.12B | ||
| -1.14% | -5.64% | +126.98% | +123.26% | 12.5B | ||
| Average | -0.92% | -1.04% | +2,274.13% | +412.12% | 22.35B | |
| Weighted average by Cap. | -0.91% | -1.20% | +1,241.48% | +242.64% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 7.57B 9.7B 8.38B 7.24B 13.19B 894B 13.56B 89.45B 35.65B 428B 36.39B 35.63B 1,541B | 7.14B 9.15B 7.91B 6.83B 12.45B 844B 12.8B 84.39B 33.64B 404B 34.34B 33.61B 1,453B |
| Net income | 1.03B 1.32B 1.14B 982M 1.79B 121B 1.84B 12.13B 4.84B 58.02B 4.94B 4.83B 209B | 1.17B 1.5B 1.3B 1.12B 2.04B 138B 2.1B 13.84B 5.52B 66.18B 5.63B 5.51B 238B |
| Net Debt | 3.46B 4.44B 3.84B 3.31B 6.04B 409B 6.21B 40.94B 16.32B 196B 16.66B 16.31B 705B | 3.23B 4.15B 3.58B 3.09B 5.64B 382B 5.8B 38.23B 15.24B 183B 15.55B 15.23B 658B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/03/26 | 489.60 CHF | -1.39% | 201,508 |
| 10/03/26 | 496.50 CHF | -0.44% | 127,275 |
| 09/03/26 | 498.70 CHF | -1.09% | 193,292 |
| 06/03/26 | 504.20 CHF | -2.02% | 161,134 |
| 05/03/26 | 514.60 CHF | -2.09% | 131,092 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LONN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















